                               SEQUENCE LISTING

<110> NOVARTIS AG
      BEARD, CLAYTON
      MARUGGI, GIULIETTA
      MASON, PETER
 
<120> ALPHAVIRUS VECTOR

<130> PAT054739-WO-PCT

<140>
<141>

<150> EP 13164381.9
<151> 2013-04-19

<160> 29    

<170> PatentIn version 3.5

<210> 1
<211> 44
<212> DNA
<213> Venezuelan equine encephalitis virus

<400> 1
atgggcggcg catgagagaa gcccagacca attacctacc caaa                        44


<210> 2
<211> 44
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 2
ataggcggcg catgagagaa gcccagacca attacctacc caaa                        44


<210> 3
<211> 44
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 3
ataggcggcg catgagagaa gcccagaccc attacctacc caaa                        44


<210> 4
<211> 44
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 4
ataggcggcg catgagagaa gcccagaccg attacctacc caaa                        44


<210> 5
<211> 59
<212> DNA
<213> Sindbis virus

<400> 5
attgacggcg tagtacacac tattgaatca aacagccgac caattgcact accatcaca        59


<210> 6
<211> 19
<212> DNA
<213> Venezuelan equine encephalitis virus

<400> 6
ttacaagagg ctggggccg                                                    19


<210> 7
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 7
ttacaagaga ttggggccg                                                    19


<210> 8
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 8
ttacaagagg ttggggccg                                                    19


<210> 9
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 9
ttacaagaga ctggggccg                                                    19


<210> 10
<211> 29
<212> DNA
<213> Venezuelan equine encephalitis virus

<400> 10
ggctcagtgg agacacctcg tggcttgat                                         29


<210> 11
<211> 29
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 11
gagtcagtgg agacacctcg tggcttgat                                         29


<210> 12
<211> 29
<212> DNA
<213> Venezuelan equine encephalitis virus

<400> 12
gcccgtacgc acaatcctta caagctttc                                         29


<210> 13
<211> 29
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 13
gcccgtacgc acaattctta caagctttc                                         29


<210> 14
<211> 63
<212> DNA
<213> Venezuelan equine encephalitis virus

<400> 14
actctctacg gctaacctga atggactacg acatagtcta gtcgacgcca ccatggtgag       60

caa                                                                     63


<210> 15
<211> 26
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 15
acgctatatg gataaatggt gagcaa                                            26


<210> 16
<211> 33
<212> RNA
<213> Venezuelan equine encephalitis virus

<400> 16
augggcggcg caugagagaa gcccagacca auu                                    33


<210> 17
<211> 33
<212> RNA
<213> Venezuelan equine encephalitis virus

<400> 17
auaggcggcg caugagagaa gcccagacca auu                                    33


<210> 18
<211> 33
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 18
auaggcggcg caugagagaa gccuagacca auu                                    33


<210> 19
<211> 33
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 19
auaggcggcg caugagagaa gcccagaccc auu                                    33


<210> 20
<211> 33
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 20
auaggcggcg caugagagaa gcccagaccg auu                                    33


<210> 21
<211> 33
<212> RNA
<213> Venezuelan equine encephalitis virus

<400> 21
aauuggucug ggcuucucuc augcgccgcc cau                                    33


<210> 22
<211> 33
<212> RNA
<213> Venezuelan equine encephalitis virus

<400> 22
aauuggucug ggcuucucuc augcgccgcc uau                                    33


<210> 23
<211> 33
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 23
aauuggucua ggcuucucuc augcgccgcc uau                                    33


<210> 24
<211> 33
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 24
aaugggucug ggcuucucuc augcgccgcc aau                                    33


<210> 25
<211> 33
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 25
aaucggucug ggcuucucuc augcgccgcc uau                                    33


<210> 26
<211> 62
<212> DNA
<213> Venezuelan equine encephalitis virus


<220>
<221> CDS
<222> (1)..(15)

<400> 26
ata act ctc tac ggc taacctgaat ggaactacga catagtctag tcgacgccac         55
Ile Thr Leu Tyr Gly                                                       
1               5                                                         

catggtg                                                                 62


<210> 27
<211> 5
<212> PRT
<213> Venezuelan equine encephalitis virus

<400> 27
Ile Thr Leu Tyr Gly 
1               5   


<210> 28
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"


<220>
<221> CDS
<222> (1)..(15)

<400> 28
ata acg cta tat gga taaatggtg                                           24
Ile Thr Leu Tyr Gly                                                       
1               5                                                         


<210> 29
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 29
Ile Thr Leu Tyr Gly 
1               5   


